Fortress Biotech, Inc. Gains 46.15%
Fri, Nov 17, 2023 at 07:49 PM
Fortress Biotech, Inc. (FBIO:NASDAQ) rocketted at $2.09, a gain of 46.2%. The stock appeared on our News Catalysts scanner on Fri, Nov 17, 2023 at 03:05 AM in the 'INSIDER' category. From Fri, Nov 03, 2023, the stock recorded 60.00% Up Days and 27.27% Green Days
About Fortress Biotech, Inc. (FBIO:NASDAQ)
Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
Top 10 Gainers:
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 900%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 180.28%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 95.85%
- Syntec Optics Holdings Inc Cl A (OPTX:NASDAQ), 73.98%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 55.24%
- Fortress Biotech, Inc. (FBIO:NASDAQ), 46.15%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 45.56%
- Local Bounti Corporation (LOCL:NYSE), 41.22%
- Safe and Green Development Corporation (SGD:NASDAQ), 38.94%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 38.45%